FI861655A0 - Förfarande för framställning av griseolinsyraderivat som används som läkemedel - Google Patents

Förfarande för framställning av griseolinsyraderivat som används som läkemedel

Info

Publication number
FI861655A0
FI861655A0 FI861655A FI861655A FI861655A0 FI 861655 A0 FI861655 A0 FI 861655A0 FI 861655 A FI861655 A FI 861655A FI 861655 A FI861655 A FI 861655A FI 861655 A0 FI861655 A0 FI 861655A0
Authority
FI
Finland
Prior art keywords
acid derivatives
medicament
preparation
derivatives used
acid
Prior art date
Application number
FI861655A
Other languages
English (en)
Finnish (fi)
Other versions
FI861655A (sv
FI94133B (sv
FI94133C (sv
Inventor
Masakatsu Kaneko
Yoshinobu Murofushi
Misako Kimura
Mitsuo Yamazaki
Yasuteru Iijima
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of FI861655A0 publication Critical patent/FI861655A0/sv
Publication of FI861655A publication Critical patent/FI861655A/sv
Priority to FI921238A priority Critical patent/FI90427C/sv
Publication of FI94133B publication Critical patent/FI94133B/sv
Application granted granted Critical
Publication of FI94133C publication Critical patent/FI94133C/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • C07H19/207—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids the phosphoric or polyphosphoric acids being esterified by a further hydroxylic compound, e.g. flavine adenine dinucleotide or nicotinamide-adenine dinucleotide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
FI861655A 1985-04-19 1986-04-18 Förfarande för framställning av griseolinsyraderivat som används som läkemedel FI94133C (sv)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FI921238A FI90427C (sv) 1985-04-19 1992-03-20 Som mellanprodukter användbara N'-alkoxi- eller N'-aralkyloxi-N6-cyano-griseolinsyraderivat

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
JP8213285 1985-04-19
JP8213285 1985-04-19
JP9198785 1985-04-27
JP9198985 1985-04-27
JP9198985 1985-04-27
JP9198785 1985-04-27

Publications (4)

Publication Number Publication Date
FI861655A0 true FI861655A0 (sv) 1986-04-18
FI861655A FI861655A (sv) 1986-10-20
FI94133B FI94133B (sv) 1995-04-13
FI94133C FI94133C (sv) 1995-07-25

Family

ID=27303820

Family Applications (1)

Application Number Title Priority Date Filing Date
FI861655A FI94133C (sv) 1985-04-19 1986-04-18 Förfarande för framställning av griseolinsyraderivat som används som läkemedel

Country Status (11)

Country Link
US (5) US5498819A (sv)
EP (1) EP0214708B1 (sv)
KR (1) KR930007385B1 (sv)
AT (2) ATE121097T1 (sv)
CA (1) CA1267409A (sv)
DE (3) DE3650429T2 (sv)
DK (1) DK167878B1 (sv)
ES (4) ES8802054A1 (sv)
FI (1) FI94133C (sv)
HK (2) HK1005738A1 (sv)
NO (1) NO169901C (sv)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO885375L (no) * 1987-12-02 1989-10-02 Sankyo Co Griseolsyremonoestere og fremgangsmaate til fremstilling derav.
US5091431A (en) * 1988-02-08 1992-02-25 Schering Corporation Phosphodiesterase inhibitors
US4971972A (en) * 1989-03-23 1990-11-20 Schering Corporation Phosphodiesterase inhibitors having an optionally substituted purine derivative portion and a benzo- or cyclopenta-furan portion
JPH04112889A (ja) * 1990-09-04 1992-04-14 Kyowa Hakko Kogyo Co Ltd Ｋｓ―５０５誘導体
US5866702A (en) * 1996-08-02 1999-02-02 Cv Therapeutics, Incorporation Purine inhibitors of cyclin dependent kinase 2
CA2238283C (en) * 1997-05-30 2002-08-20 Cell Pathways, Inc. Method for identifying compounds for inhibition of neoplastic lesions, pharmaceutical compositions from such compounds and uses of such compounds and compositions for treating neoplastic lesions
US6558787B1 (en) * 1999-12-27 2003-05-06 Kodak Polychrome Graphics Llc Relation to manufacture of masks and electronic parts
EP1312363A1 (en) * 2001-09-28 2003-05-21 Pfizer Products Inc. Methods of treatment and kits comprising a growth hormone secretagogue
US7342884B2 (en) * 2002-03-13 2008-03-11 Harmonic, Inc. Method and apparatus for one directional communications in bidirectional communications channel
US20040043014A1 (en) * 2002-08-30 2004-03-04 Hiroyoshi Moriyama Platelet aggregation inhibitor and supplement food effective for inhibiting platelet aggregation
US20050130971A1 (en) * 2003-08-22 2005-06-16 Pharmacia Corporation Compositions of a cyclooxygenase-2 selective inhibitor and phosphodiesterase inhibitor for the treatment of ischemic mediated central nervous system disorders or injury
GB0601951D0 (en) 2006-01-31 2006-03-15 Novartis Ag Organic compounds
WO2011081915A2 (en) * 2009-12-15 2011-07-07 Cebix Inc. Methods for treating erectile dysfunction in patients with insulin-dependent diabetes
BR112016002870B1 (pt) 2013-08-12 2020-11-24 Saudi Basic Industries Corporation Sistema catalisador para polimerizacao de uma olefina, seu processo de preparação, processo para preparar uma poliolefina, poliolefina obtenivel do mesmo, artigo moldado e uso

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4035370A (en) * 1971-11-03 1977-07-12 Richter Gedeon Vegyeszeti Gyar Rt. Alkaloid esters
US4167565A (en) * 1976-11-08 1979-09-11 Abbott Laboratories Adenosine-5'-carboxamides and method of use
JPS5668695A (en) * 1979-11-10 1981-06-09 Sankyo Co Ltd Enzyme inhibitor griseolic acid and its preparation
US4803271A (en) * 1982-02-01 1989-02-07 Syntex (U.S.A.) Inc. Process for preparing guanine derivatives
US4783532A (en) * 1983-10-28 1988-11-08 Sankyo Company Limited Process for preparing griseolic acid derivatives
JPS6094992A (ja) * 1983-10-28 1985-05-28 Sankyo Co Ltd グリゼオ−ル酸誘導体
JPS60246396A (ja) * 1984-05-22 1985-12-06 Sankyo Co Ltd 酵素阻害物質ジヒドロデスオキシグリゼオ−ル酸及びその塩類
US4788190A (en) * 1986-12-24 1988-11-29 Schering Corporation 2,4,4-tri- and 2,2,4,4-tetra substituted-1,3-dioxolane antifungal, antiallergy compounds
US5091431A (en) * 1988-02-08 1992-02-25 Schering Corporation Phosphodiesterase inhibitors
US4966912A (en) * 1989-09-29 1990-10-30 Uniroyal Chemical Company, Inc. Fungicidal 3-imino-1,4-oxathiins
JPH0559085A (ja) * 1990-12-27 1993-03-09 Nippon Kayaku Co Ltd イミダゾール塩基を有するオキセタノシン誘導体
JPH0639472B2 (ja) * 1991-12-21 1994-05-25 メルシャン株式会社 アゾール誘導体

Also Published As

Publication number Publication date
DE3667470D1 (de) 1990-01-18
DK179586A (da) 1986-10-20
FI861655A (sv) 1986-10-20
ES8801666A1 (es) 1988-02-16
HK1005738A1 (en) 1999-01-22
DE3650297T2 (de) 1996-01-25
DK167878B1 (da) 1993-12-27
US5616600A (en) 1997-04-01
FI94133B (sv) 1995-04-13
NO169901B (no) 1992-05-11
NO861533L (no) 1986-11-21
ES8801664A1 (es) 1988-02-16
ES557560A0 (es) 1988-02-16
US5532369A (en) 1996-07-02
US5556975A (en) 1996-09-17
US5498819A (en) 1996-03-12
FI94133C (sv) 1995-07-25
EP0214708A2 (en) 1987-03-18
DE3650297D1 (de) 1995-05-18
ATE121097T1 (de) 1995-04-15
HK1005739A1 (en) 1999-01-22
EP0214708B1 (en) 1989-12-13
DE3650429D1 (de) 1995-11-30
KR930007385B1 (ko) 1993-08-09
KR860008206A (ko) 1986-11-14
ES554178A0 (es) 1988-03-16
CA1267409A (en) 1990-04-03
NO169901C (no) 1992-08-19
US5760042A (en) 1998-06-02
EP0214708A3 (en) 1987-08-26
ES8802054A1 (es) 1988-03-16
DK179586D0 (da) 1986-04-18
ES557559A0 (es) 1988-02-16
DE3650429T2 (de) 1996-06-13
ES557558A0 (es) 1988-02-16
ATE129501T1 (de) 1995-11-15
ES8801665A1 (es) 1988-02-16

Similar Documents

Publication Publication Date Title
FI861655A0 (sv) Förfarande för framställning av griseolinsyraderivat som används som läkemedel
ES2130111T3 (es) Derivados de ciclohexano, preparaciones que los contienen y su utilizacion.
DE68918406D1 (de) Xanthinderivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Präparate.
ES2037095T3 (es) Un procedimiento para preparar una composicion farmaceutica.
EP0294069A3 (en) Purine compounds, process for their preparation, intermediates and pharmaceutical compositions
EP0319050A3 (en) Griseolic acid derivatives, their preparation and their use
PT82634A (en) Process for preparing novel alkaloid compounds containing a berban skeleton useful as medicaments
FI885638A (sv) Förfarande för framställning av monoesterderivat av griseolinsyra, vilka är användbara som läkemedel
RU93005243A (ru) Производные гризеоловой кислоты
ES8406488A3 (es) Procedimiento para la preparacion de derivados de norescopolamina racemicos u opticamente activos.

Legal Events

Date Code Title Description
BB Publication of examined application
MM Patent lapsed

Owner name: SANKYO COMPANY LIMITED